FULL PAPERS
matography
(silica
gel,
hexanes:
1.41 (m, 2H), 1.37–1.23 (m,4H), 0.95–0.85 (m, 3H);
13C NMR (100 MHz, CDCl3): d=137.1, 118.0, 64.3, 63.0,
47.0, 29.7, 29.6, 22.6, 14.2; FT-IR-ATR: n=3298, 2927, 2857,
1457, 1048 cmÀ1; HR-MS (ESI-TOF): m/z=337.2859 [2M+
Na]+, calcd. for C18H38N2NaO2: 337.2831.
EtOAc, 1:1) to give 10 as a colourless oil; yield:18 mg
(93%). HPLC [Daicel Chiralcel OD-H, n-hexane:i-PrOH,
85:15, flow=0.5 mLminÀ1, detection, UV 210 nm]: retention
times (min), 11.67 (95.18%), 14.89 (4.82%); 90% ee; [a]2D5:
1
À6.8 (c 0.6, CHCl3); H NMR (400 MHz, CDCl3): d=7.36–
(E)-4-(Pyrrolidin-1-yl)but-2-en-1-ol (17):[39] Carbonate 2a
was treated with pyrrolidine (14) following the general pro-
cedure. The reaction crude was purified by flash column
chromatography (silica gel, EtOAc) to give compound 17 as
a colourless oil; yield: 11 mg (69%). 1H NMR (400 MHz,
CDCl3): d=5.91–5.72 (m, 2H), 4.15–4.09 (m, 2H), 3.15–3.09
(m, 2H), 2.57–2.50 (m, 4H), 1.83–1.76 (m, 4H); 13C NMR
(100 MHz, CDCl3): d=133.5, 127.8, 59.8, 53.8, 52.4, 23.5.
(E)-4-(Dibenzylamino)but-2-en-1-ol (18):[40] Carbonate 2a
was treated with dibenzylamine (15) following the general
procedure. The reaction crude was purified by flash column
chromatography (silica gel, hexanes:EtOAc, 1:1) to give
compound 18 as a colourless oil; yield: 21 mg (71%).
1H NMR (400 MHz, CDCl3): d=7.43–7.16 (m, 10H), 5.83–
5.71 (m, 2H), 4.10 (d, J=4.3 Hz, 2H), 3.58 (s, 4H), 3.07 (d,
J=4.8 Hz, 2H).
7.30 (m, 3H), 7.29–7.24 (m, 2H), 5.75–5.64 (m, 1H), 5.29–
5.20 (m, 2H), 3.89 (d, J=13.0 Hz, 1H), 3.69 (d, J=13.0 Hz,
1H), 3.63 (dd, J=10.6, 4.5 Hz, 1H), 3.40 (dd, J=10.6,
7.9 Hz, 1H), 3.24 (td, J=7.8, 4.6 Hz, 1H); 13C NMR
(100 MHz, CDCl3): d=140.0, 137.2, 128.6, 128.4, 127.3,
118.1, 64.7, 62.2, 51.0; FT-IR-ATR: n=3303, 2926,
2851 cmÀ1; HR-MS (ESI-TOF): m/z=178.1199 [M+H]+,
calcd. for C11H16NO: 178.1226.
(À)-(R)-2-(3,4-Dimethoxyphenethylamino)but-3-en-1-ol
(11): Carbonate 2a was treated with 2-(3,4-dimethoxyphen-
ACHTUNGTRENNUNGyl)ethanamine (7) following the general procedure. The re-
action crude was purified by flash column chromatography
(silica gel, hexanes:EtOAc, 1:1) to give 11 as a colourless
oil; yield: 28 mg (96%). HPLC [Daicel Chiralcel OD-H,
heptane (0.1% DEA):EtOH, 95:5, flow=1 mLminÀ1, detec-
tion, UV 210 nm]: retention times (min), 25.97 (97.3%),
(E)-4-(tert-Butylamino)but-2-en-1-ol (19): Carbonate 2a
was treated with tert-butylamine 16 following the general
procedure. The reaction crude was purified by flash column
chromatography (silica gel, CH2Cl2:MeOH) to give com-
29.11 (2.7%); 95% ee; [a]2D0: À15.5 (c 0.18, CHCl3); H NMR
1
(400 MHz, CDCl3): d=6.83–6.70 (m, 3H), 5.62 (ddd, J=
17.0 Hz, J=10.7 Hz, 7.6 Hz, 1H), 5.17 (d, J=10.7 Hz, 1H),
5.15 (d, J=17.0 Hz, 1H), 3.87 (s, 3H), 3.85 (s, 3H), 3.58 (dd,
J=10.4 Hz, 4.5 Hz, 1H), 3.33 (dd, J=10.4 Hz, 7.9 Hz, 1H),
3.22–3.15 (m, 1H), 3.00–2.67 (m, 4H); 13C NMR (100 MHz,
CDCl3): d=149.0, 147.6, 137.5, 132.5, 120.7, 117.6, 112.0,
111.4, 64.6, 62.8, 56.0, 56.0, 48.5, 36.2; FT-IR-ATR: n=3297,
2927, 1514, 1260, 1026 cmÀ1; HR-MS (ESI-TOF): m/z=
252.1592 [M+H]+, calcd. for C14H22NO3: 252.1594.
1
pound 19 as a colourless oil; yield: 10 mg (60%). H NMR
(400 MHz, CDCl3): d=5.83–5.79 (m, 2H), 4.13–4.08 (m,
2H), 3.21 (d, J=4.6 Hz, 2H), 2.30 (bs, 1H), 1.13 (s, 9H);
13C NMR (100 MHz, CDCl3): d=131.4, 130.1„ 63.0, 51.1,
44.3, 28.8; HR-MS (ESI-TOF): m/z=166.1225 [M+Na]+,
calcd. for C8H17NNaO: 166.1202.
(E)-4-[(1-Hydroxybut-3-en-2-yl)(pent-4-en-1-yl)amino]-
but-2-en-1-ol (22): Carbonate 2a (0.068 g, 0.464 mmol) was
treated with pentan-1-amine 20 (0.0197 g, 0.232 mmol) fol-
lowing the general procedure. The reaction crude was puri-
fied by flash column chromatography (silica gel, EtOAc:-
MeOH, 9:1) to give 22 as a colourless oil; yield: 45 mg
(86%).1H NMR (400 MHz, CDCl3): d=5.86–5.62 (m, 4H),
5.27 (ddd, J=10.5 Hz, 1.7 Hz, 0.6 Hz, 1H), 5.15 (ddd, J=
17.2 Hz, 1.7 Hz, 0.9 Hz, 1H), 4.16–4.12 (m, 2H), 4.14 (d, J=
5.4 Hz, 2H), 3.49–3.44 (m, 2H) 3.38–3.26 (m, 2H), 2.95 (dd,
J=14.4 Hz, 7.5 Hz, 1H), 2.63–3.53 (m, 1H), 2.33 (ddd, J=
13.0 Hz, 8.3 Hz, 4.6 Hz, 1H), 2.14–1.96 (m, 2H), 1.64–1.47
(m, 2H); 13C NMR (100 MHz, CDCl3): d=138.4, 132.6,
132.2, 130.1, 120.1, 114.9, 63.6, 63.3, 60.8, 51.7, 48.7, 31.5,
27.6; FT-IR-ATR: n=3366, 2924, 1418, 997, 912 cmÀ1; HR-
MS (ESI-TOF): m/z=226.1830 [M+H]+, calcd. for
C13H24NO2: 226.1802.
(À)-(R)-2-(Cyclohexylamino)but-3-en-1-ol (12): Following
the general procedure carbonate 2a was treated with cyclo-
hexanamine (8).The reaction crude was purified by flash
column chromatography (silica gel, EtOAc:MeOH, 9:1) to
give 12 as a white foam; yield: 18 mg (91%). HPLC [Daicel
Chiralcel
OD-H,
n-hexane:i-PrOH,
85:15,
flow=
0.5 mLminÀ1, detection, UV 306 nm]: retention times (min),
6.54 (99.14%), 5.59 (0.86%); 98% ee; [a]2D5: À25.0 (c 0.72,
1
CHCl3); H NMR (400 MHz, CDCl3): d=5.71–5.60 (m, 1H),
5.20–5.14 (m, 2H), 3.59–3.53 (m, 1H), 3.36–3.25 (m, 2H),
2.52 (tt, J=10.3 Hz, 3.8 Hz, 1H), 2.32 (bs, 1H), 1.94–1.86
(m, 1H), 1.82–1.67 (m, 3H), 1.63–1.54 (m, 1H), 1.33–1.09
(m, 4H), 1.07–0.94 (m, 1H):; 13C NMR (100 MHz, CDCl3):
d=138.1, 117.0, 64.7, 59.1, 53.6, 37.7, 33.3, 26.2, 25.2, 24.8;
FT-IR-ATR: n=3248, 2923, 2855, 1088 cmÀ1; HR-MS (ESI-
TOF): m/z=170.1567 [M+H]+, calcd. for C10H20NO:
170.1539.
(+)-(S)-2-(But-3-enylamino)but-3-en-1-ol (24): Carbonate
2a was treated with but-3-en-1-amine (23) in the presence of
the (R,R)-DACH naphthyl ligand following the general pro-
cedure. The reaction crude was purified by flash column
chromatography (silica gel, EtOAc:MeOH, 9:1) to give 24
as a colourless oil; yield: 14 mg (91%). HPLC [Daicel Chir-
alcel OD-H, n-hexane:i-PrOH, 85:15, flow=0.5 mLminÀ1,
detection, UV 280 nm]: retention times (min), 11.7 (3%),
(À)-(R)-2-(Pentylamino)but-3-en-1-ol (13): Carbonate 2a
was treated with pentan-1-amine (9) following the general
procedure. The reaction crude was purified by flash column
chromatography (silica gel, EtOAc:MeOH, 9:1) to give
compound 13 as a colourless oil; yield: 16 mg (90%). HPLC
[Daicel Chiralcel OD-H, n-hexane:i-PrOH, 85:15, flow=
0.5 mLminÀ1, detection, UV 313 nm]: retention times (min),
6.23 (98.18%), 7.81 (1.82%); 96% ee; [a]2D5: À9.9 (c 1.15,
1
13.4 (97%); 94% ee; [a]2D5: +12.1 (c 4.1, CHCl3); H NMR
1
CHCl3); H NMR (400 MHz, CDCl3): d=5.73–5.61 (m, 1H),
(400 MHz, CDCl3): d=5.78 (tdd, J=17.0 Hz, 10.1 Hz,
6.8 Hz, 1H), 5.64 (ddd, J=17.2 Hz, 10.6 Hz, 7.6 Hz, 1H),
5.23–5.17 (m, 2H), 5.14–5.01 (m, 2H), 3.59 (dd, J=10.5 Hz,
4.5 Hz, 1H), 3.35 (dd, J=10.5 Hz, 8.0 Hz, 1H), 3.22–3.13
(m, 1H), 2.76 (td, J=11.2 Hz, 7.0 Hz, 1H), 2.56 (td, J=
5.26–5.17 (m, 2H), 3.62 (dd, J=10.6 Hz, 4.7 Hz, 1H), 3.39
(dd, J=10.6 Hz, 7.8 Hz, 1H), 3.20 (tdt, J=7.8 Hz, 4.7 Hz,
0.9 Hz, 1H), 2.85 (bs, 1H), 2.71 (ddd, J=11.4 Hz, 8.1 Hz,
6.6 Hz, 1H), 2.50 (ddd, J=11.4 Hz, 8.1, 6.4 Hz, 1H), 1.58–
Adv. Synth. Catal. 0000, 000, 0 – 0
8
ꢄ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÞÞ
These are not the final page numbers!